Aurobindo Pharma gets nod from US FDA for anti-HIV drug

Aurobindo Pharma Limited, a manufacturer of generic pharmaceuticals and active pharmaceutical ingredients, has received final approval from the US Food and Drug Administration (US FDA) to manufacture and market the earlier tentatively-approved Abacavir tablets in 300 mg strength.
The product, which has been approved out of Aurobindo’s Unit-III formulations facility in Hyderabad, is ready for launch is a anti-retroviral combination therapy for the treatment of human immunodeficiency virus

Aurobindo Pharma ltd, anti-retroviral combination therapy Aurobindo,the treatment of human immunodeficiency, US FDA for anti-HIV drug, HIV US FDA, immunodeficiency virus